HealthFab, a Bengaluru startup focused on menstrual hygiene, has raised Rs 20 crore from Atomic Capital. The capital injection will support expanding its offerings beyond period underwear toward a full-spectrum period care platform, while also strengthening its offline presence and R&D efforts.
- Rs 20 crore funding from Atomic Capital boosts HealthFab
- Expansion into comprehensive period care solutions underway
- Focus on offline retail growth and research innovation
What happened
HealthFab, a Bengaluru-based startup specializing in menstrual hygiene products, has secured Rs 20 crore in funding from venture firm Atomic Capital. Founded with the goal of addressing period care through direct-to-consumer sales, HealthFab has built a user base of around 5 lakh customers to date.
The fresh capital infusion is earmarked for diversifying the company’s product portfolio beyond its flagship period underwear. HealthFab intends to develop a platform that integrates solutions addressing period-related issues such as pain, sleep disturbances, and energy management, enhancing overall menstrual health care.
Why it matters
HealthFab’s extension from a niche product into a holistic period care platform reflects a broader trend in India’s growing femtech sector. By tackling multiple facets of menstrual wellness, the startup aims to deepen consumer engagement and improve health outcomes, which can set new standards in the largely underserved category.
Moreover, boosting offline presence is strategic for capturing wider demographics in India, where physical retail continues to be influential. Increased investment in research and development signals HealthFab’s commitment to innovation and product efficacy to stay competitive in an evolving market.
What to watch next
Industry observers will be watching how HealthFab's new product lines perform in the competitive Indian femtech landscape, especially their effectiveness in addressing pain, sleep, and energy during menstruation. Consumer adoption and feedback will be crucial indicators of market acceptance.
The company’s offline expansion will also be a key area of focus, assessing how well it leverages physical retail channels for growth alongside its existing online base. Lastly, tracking further R&D initiatives will provide insights into HealthFab’s innovation trajectory and potential to drive advancements in menstrual care.